Charles River Laboratories International, Inc. (NYSE:CRL) Gi

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The […]

Related Keywords

United States , Canada , America , Richardf Wallman , Asia Pacific , Jamesc Foster , Covestor Ltd , Charles River Laboratories International Inc , Lindbrook Capital , Desjardins Global Asset Management Inc , Venturi Wealth Management , Wells Fargo Company , Research Models , Charles River Laboratories International Stock , Analyst Recommendations For Charles River Laboratories International , Manufacturing Solutions , Securities Exchange Commission , Charles River Laboratories International , Get Free Report , Director Richard , Exchange Commission , Wealth Management , Global Asset Management , River Laboratories International , Get Free , Safety Assessment , Charles River Laboratories International Daily , Nyse Crl , Crl , Medical , 15986410 , Ratings , Consensus ,